Yogeeta O. Agrawal

Dhulia, MH 424001, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Chondroitin sulfate-functionalized ultradeformable liposomes for dual effect in rheumatoid arthritis: systematic QbD development and in vivo characterization.

Chondroitin sulfate-functionalized ultradeformable liposomes for dual effect in rheumatoid arthritis: systematic QbD development and in vivo characterization.

Journal: International journal of pharmaceutics

Published: February 25, 2026

Neuroprotective efficacy of hentriacontane against rotenone-induced apoptosis in SH-SY5Y cells: In silico and in vitro evidence of GSK3β association.

Neuroprotective efficacy of hentriacontane against rotenone-induced apoptosis in SH-SY5Y cells: In silico and in vitro evidence of GSK3β association.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: October 13, 2025

Interlinked Microbiota-Metabolite-Epigenome Dynamics in the Gut-Heart-Ovary Axis: New Perspectives on Cardiometabolic Risk in Polycystic Ovary Syndrome.

Interlinked Microbiota-Metabolite-Epigenome Dynamics in the Gut-Heart-Ovary Axis: New Perspectives on Cardiometabolic Risk in Polycystic Ovary Syndrome.

Journal: Current topics in medicinal chemistry

Published: September 19, 2025

Advances in Capsaicin-Based Nanocarriers: Bridging Mechanistic Insights with Therapeutic Potential and Clinical Outcomes.

Advances in Capsaicin-Based Nanocarriers: Bridging Mechanistic Insights with Therapeutic Potential and Clinical Outcomes.

Journal: Assay and drug development technologies

Published: September 02, 2025

Harnessing the Potential of Natural Nutraceuticals Against Huntington's Disease.

Harnessing the Potential of Natural Nutraceuticals Against Huntington's Disease.

Journal: Current topics in medicinal chemistry

Published: August 05, 2025

Hentriacontane alleviates streptozotocin-induced Alzheimer's disease-like conditions in rats: In silico and in vivo investigations revealed the unifying principles.

Hentriacontane alleviates streptozotocin-induced Alzheimer's disease-like conditions in rats: In silico and in vivo investigations revealed the unifying principles.

Journal: Computers in biology and medicine

Published: August 04, 2025

Protective Effect of "Ark-e-Kasni," a Unani Formulation, in Letrozole and High-Fat Diet-Induced Polycystic Ovarian Syndrome in Rats.

Protective Effect of "Ark-e-Kasni," a Unani Formulation, in Letrozole and High-Fat Diet-Induced Polycystic Ovarian Syndrome in Rats.

Journal: The journal of obstetrics and gynaecology research

Published: August 01, 2025

Intracerebroventricular streptozotocin-induced animal model of Alzheimer's disease: revealing dose optimization, administration regimen, and molecular pathways.

Intracerebroventricular streptozotocin-induced animal model of Alzheimer's disease: revealing dose optimization, administration regimen, and molecular pathways.

Journal: Laboratory animal research

Published: July 31, 2025

β-Caryophyllene Ameliorates STZ-Induced Alzheimer's Disease-Like Conditions in Rats via Modulation of Brain-Derived Neurotrophic Factor, Synaptic Plasticity, and Neuroinflammation.

β-Caryophyllene Ameliorates STZ-Induced Alzheimer's Disease-Like Conditions in Rats via Modulation of Brain-Derived Neurotrophic Factor, Synaptic Plasticity, and Neuroinflammation.

Journal: The European journal of neuroscience

Published: July 29, 2025

Unraveling PCOS therapies: Pharmacotherapeutic strategies and emerging therapeutic targets.

Unraveling PCOS therapies: Pharmacotherapeutic strategies and emerging therapeutic targets.

Journal: Pathology, research and practice

Published: July 01, 2025

Nanostructured lipid nanocarrier scaffold of ranolazine: preparation, optimization, in vitro and in vivo evaluations.

Nanostructured lipid nanocarrier scaffold of ranolazine: preparation, optimization, in vitro and in vivo evaluations.

Journal: Journal of microencapsulation

Published: June 21, 2025

Computational screening of natural phenolic compounds as potential EGFR inhibitors against triple negative breast cancer.

Computational screening of natural phenolic compounds as potential EGFR inhibitors against triple negative breast cancer.

Journal: Journal of molecular modeling

Published: March 18, 2025

Showing 1-12 of 54

Last Updated: 09/26/2026